In radiotherapy, HMGB1 both activates anti-tumor immunity and aids DNA repair, interacting with Ku70 in nasopharyngeal carcinoma and modulating the TLR4/NF-κB axis in lung cancer. Here, HMGB1 is linked to neoplasm.